Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
Status:
Completed
Trial end date:
2009-10-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of HMPL-004 in patients with
active mild to moderate ulcerative colitis (UC), compared with placebo.